Researchers tagged mouse RNA with the enzyme that makes fireflies glow, in hopes of better understanding how viruses and ...

Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company ...

Ethris announces promising phase 1 results for ETH47, its mRNA therapy for uncontrolled asthma. The inhaled treatment showed strong safety and efficacy, with plans for a phase 2 trial in 2025.

"Everything injected into the bloodstream is eventually ends up in the liver — that's just how our anatomy works," Professor ...

Researchers at Tel Aviv University have achieved a breakthrough in drug delivery: they have successfully transported lipid ...

Fintel reports that on January 28, 2025, BTIG initiated coverage of Arcturus Therapeutics Holdings (NasdaqGM:ARCT) with a Buy ...

In a move to bolster global health cooperation, China has pledged its unwavering support for the World Health Organization ...

Ramakrishnan, a distinguished structural biologist and Nobel Laureate in Chemistry (2009), is renowned for his groundbreaking ...

The Stargate Project, a $500B initiative focused on artificial intelligence, lifts AI-driven biotech stocks and an unlikely ...

While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.